Hemagen Diagnostics (Hemagen Diagnostics) EV-to-Revenue : 0.00 (As of Jun. 09, 2024)

Hemagen Diagnostics EV-to-Revenue Chart

Hemagen Diagnostics Annual Data
	Trend	Sep03	Sep04	Sep05	Sep06	Sep07	Sep08	Sep09	Sep10	Sep11	Sep12
EV-to-Revenue		Get a 7-Day Free Trial					1.00	1.02	1.00	0.97	1.36

Hemagen Diagnostics Quarterly Data
	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12
EV-to-Revenue	Get a 7-Day Free Trial															0.97	1.04	1.12	1.28	1.36

Competitive Comparison of Hemagen Diagnostics's EV-to-Revenue

For the Biotechnology subindustry, Hemagen Diagnostics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemagen Diagnostics's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hemagen Diagnostics's EV-to-Revenue falls into.

Hemagen Diagnostics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hemagen Diagnostics's EV-to-Revenue for today is calculated as:

Hemagen Diagnostics's current Enterprise Value is $0.00 Mil.
Hemagen Diagnostics's Revenue for the trailing twelve months (TTM) ended in Sep. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemagen Diagnostics  (OTCPK:HMGN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hemagen Diagnostics's PS Ratiofor today is calculated as:

Hemagen Diagnostics's share price for today is $0.0001.
Hemagen Diagnostics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.26.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemagen Diagnostics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemagen Diagnostics (Hemagen Diagnostics) Business Description